Evidence map›Paper›PMID 40701793›Full record

ArticleGut2025

Mitochondrial dysfunction drives basal cell hyperplasia in eosinophilic oesophagitis.

Masaki Morimoto, Kento Kawasaki, Niamh McNamee, Samuel Flashner, Rieko Shimonosono, Masataka Shimonosono, Norihiro Matsuura, Yasuto Tomita, Wataru Hirose, Ryugo Teranishi and 20 more

Abstract read
In one paragraph

Article in Gut, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Masaki MorimotoColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.ORCID 0000-0001-5937-4056
Kento KawasakiColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Niamh McNameeMassachusetts General Hospital, Boston, Massachusetts, USA.
Samuel FlashnerColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Rieko ShimonosonoColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Masataka ShimonosonoColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Norihiro MatsuuraColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Yasuto TomitaColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Wataru HiroseColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Ryugo TeranishiDivision of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-9337-0526
Takefumi ItamiDivision of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Manti GuhaColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Pavithra RajagopalanMassachusetts General Hospital, Boston, Massachusetts, USA.
Cecilia MartinColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Hailey GoldenDivision of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Diya DhakalDivision of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Benjamin J WilkinsDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Andres J Klein-SzantoHistopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Kirk J WangensteenDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Julian A AbramsColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.ORCID 0000-0002-6021-9376
Sydney PomentiDivision of Digestive & Liver Diseases, Department of Medicine, Columbia University, New York, New York, USA.
David A KatzkaColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.ORCID 0000-0003-2307-2317
Jianwen QueColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Kelly A WhelanFels Cancer Institute for Personalized Medicine, Department of Cancer & Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Amanda B MuirDivision of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Hirohito KitaDivision of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Benjamin L WrightDivision of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, Arizona, USA.ORCID 0000-0002-7586-4722
Alfred D DoyleDivision of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Hiroshi NakagawaColumbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA uma.sachdeva@mgh.harvard.edu hn2360@cumc.columbia.edu.
Uma M SachdevaMassachusetts General Hospital, Boston, Massachusetts, USA uma.sachdeva@mgh.harvard.edu hn2360@cumc.columbia.edu.ORCID 0000-0002-0442-3794

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI Irene M. Ghobrial · 1985 to 2026
$330.6M
WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Eric Andrew Ross · 1985 to 2026
$138.8M
Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
Transformed Esophageal Epithelial Cells and the Tumor MicroenvironmentP01CA098101 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RUSTGI, ANIL K · 2003 to 2023
$31.7M
The Organoid and Cell Culture CoreP30DK132710 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Robert F. Schwabe · 2022 to 2026
$7.2M
Autophagy and esophageal tissue remodeling in EoER01DK114436 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI NAKAGAWA, HIROSHI · 2017 to 2024
$3.1M
Aldh2 and mitochondrial homeostasis in esophageal pathobiologyR01AA026297 · NIAAA · UNIVERSITY OF PENNSYLVANIA · PI Hiroshi Nakagawa · 2018 to 2026
$2.9M
Genome and Epigenome Integrity In CancerT32CA265828 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Alberto Ciccia, Chao Lu · 2022 to 2026
$1.8M
Post-transcriptional modification in esophageal basal cells.R01DK144271 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jianwen Que · 2025 to 2026
$1.6M
Mechanisms of adverse gastrointestinal events during oral immunotherapyK23AI158813 · NIAID · MAYO CLINIC ARIZONA · PI Benjamin L. Wright · 2022 to 2026
$949k
Multidisciplinary Training in Gastrointestinal CancersT32CA285274 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Julian Abrams, Anil K Rustgi · 2024 to 2026
$897k
NCATS NIH HHS UL1 TR002541NCI NIH HHS L30 CA264714NCI NIH HHS P01 CA098101NCI NIH HHS P30 CA006516NCI NIH HHS P30 CA006927NCI NIH HHS P30 CA013696NCI NIH HHS T32 CA265828NCI NIH HHS T32 CA285274NIAAA NIH HHS R01 AA026297NIAID NIH HHS K23 AI158813NIDDK NIH HHS P30 DK132710NIDDK NIH HHS R01 DK114436NIDDK NIH HHS R01 DK144271
6 · The paper itself

Abstract

backgroundEosinophilic oesophagitis (EoE) is a food allergen-induced inflammatory disorder characterised by interleukin (IL)-13-mediated oesophageal inflammation and epithelial basal cell hyperplasia (BCH). The role of mitochondria in EoE pathogenesis remains elusive.

designPrompted by single cell transcriptomics data, we interrogated the role of mitochondria in EoE pathobiology using patient biopsies, EoE-mouse models and oesophageal epithelial cells grown in monolayer and three-dimensional (3D) organoid cultures treated with EoE-relevant cytokines. 3D organoids and EoE-bearing mice were treated with omeprazole-a proton-pump inhibitor used as first-line EoE therapy. We performed CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) interference in mouse organoids to identify the key mitochondrial regulatory genes whose depletion may lead to BCH. We analysed mitochondrial membrane potential, mass and superoxide production by flow cytometry, cellular oxygen consumption by respirometry, mitochondrial structures and perturbation of cellular energy homeostasis by immunoblotting. 

resultsMitochondrial dysfunction appeared to be a hallmark of EoE-related BCH where mitochondrial structural damage was associated with impaired oxidative respiratory capacity, elevation of mitochondrial superoxide and decreased adenosine triphosphate (ATP) production, as corroborated by activation of the adenosine monophosphate (AMP) -activated protein kinase and suppression of mammalian target-of-rapamycin signalling. Depletion of PGC1A, the master regulator of mitochondria biogenesis, recapitulated EoE-related BCH, suggesting that mitochondrial dysfunction drives BCH. Further, omeprazole alleviated mitochondrial damage and dysfunction in EoE-related BCH modelled in mice and patient-derived organoids. 

conclusionMitochondrial dysfunction is tightly linked to perturbation of redox homeostasis in EoE-related BCH, which is promoted by IL-13 and reversible with omeprazole treatment.

Indexed as

Eosinophilic EsophagitisMitochondriaAnimalsDisease Models, AnimalEpithelial CellsEsophagusHumansHyperplasiaMiceOmeprazoleOrganoidsProton Pump InhibitorsOmeprazoleProton Pump InhibitorsGASTROINTESTINAL IMMUNE RESPONSEINFLAMMATORY DISEASESOESOPHAGITIS

Identifiers

PMID40701793
PMCPMC12438975

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.